Employers need approaches that balance access with sustainability
It requires ongoing care, support and the right tools to stay on track
8 Armstrong D, Dregan A, Ashworth M, White P
Blood Glucose GLP-1s effectively lower blood glucose levels Research shows that GLP-1RAs significantly improve glycemic control by enhancing insulin secretion and inhibiting glucagon release, leading to better management of blood sugar levels Cardiovascular Health GLP-1s are associated with a lower risk of major cardiovascular events Meta-analyses reveal that GLP-1RAs reduce the risk of cardiovascular death, non-fatal heart attack, and stroke, offering substantial cardiovascular protection for patients Kidney Health Preserving kidney function Studies suggest that GLP-1RAs help in preserving kidney function and reducing the progression of kidney disease in patients with type 2 diabetes On average, people on GLP-1 Medications lose 1.5% of their weight per week* This product is absolutely incredible
According to estimates, atopic diseases affect 25-30% of the global population
Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis